Novartis (Signifor,Signifor LAR and Osilodrostat) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Novartis (Signifor,Signifor LAR and Osilodrostat) General Information
Description
Medical rights for the treatment of Cushing disease. The rights are used for the treatment of Cushing's disease and acromegaly in adult patients for whom surgery is not an option or for whom surgery has failed.
Contact Information
Corporate Office
- Basel
- Switzerland
Corporate Office
- Basel
- Switzerland
Novartis (Signifor,Signifor LAR and Osilodrostat) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis (Signifor,Signifor LAR and Osilodrostat) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis (Signifor,Signifor LAR and Osilodrostat) FAQs
-
Where is Novartis (Signifor,Signifor LAR and Osilodrostat) headquartered?
Novartis (Signifor,Signifor LAR and Osilodrostat) is headquartered in Basel, Switzerland.
-
What industry is Novartis (Signifor,Signifor LAR and Osilodrostat) in?
Novartis (Signifor,Signifor LAR and Osilodrostat)’s primary industry is Buildings and Property.
-
Is Novartis (Signifor,Signifor LAR and Osilodrostat) a private or public company?
Novartis (Signifor,Signifor LAR and Osilodrostat) is a Private company.
-
What is the current valuation of Novartis (Signifor,Signifor LAR and Osilodrostat)?
The current valuation of Novartis (Signifor,Signifor LAR and Osilodrostat) is .
-
What is Novartis (Signifor,Signifor LAR and Osilodrostat)’s current revenue?
The current revenue for Novartis (Signifor,Signifor LAR and Osilodrostat) is .
-
Who are Novartis (Signifor,Signifor LAR and Osilodrostat)’s investors?
Novartis has invested in Novartis (Signifor,Signifor LAR and Osilodrostat).
-
When was Novartis (Signifor,Signifor LAR and Osilodrostat) acquired?
Novartis (Signifor,Signifor LAR and Osilodrostat) was acquired on 23-Oct-2019.
-
Who acquired Novartis (Signifor,Signifor LAR and Osilodrostat)?
Novartis (Signifor,Signifor LAR and Osilodrostat) was acquired by Recordati.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process